How much is a share of axdx worth?
One share of AXDX stock can currently be purchased for approximately $3.72. How much money does Accelerate Diagnostics make? Accelerate Diagnostics has a market capitalization of $228.78 million and generates $11.16 million in revenue each year.
What price target do analysts set for axdx?
What price target have analysts set for AXDX? 1 brokerages have issued twelve-month target prices for Accelerate Diagnostics' stock. Their forecasts range from $9.00 to $9.00. On average, they anticipate Accelerate Diagnostics' share price to reach $9.00 in the next year. This suggests a possible upside of 141.9% from the stock's current price.
Who sold accelerate diagnostics (axdx) stock?
AXDX stock was sold by a variety of institutional investors in the last quarter, including Chicago Capital LLC. Company insiders that have sold Accelerate Diagnostics company stock in the last year include Jack Phillips, Ron Price, and Steven Reichling.
How do I contact axdx?
The medical research company can be reached via phone at (520) 365-3100, via email at [email protected], or via fax at 520-269-6580. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks.
Should I buy or sell Accelerate Diagnostics stock right now?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Accelerate Diagnostics in the last year. There are currently 1 sell rating...
What is Accelerate Diagnostics' stock price forecast for 2022?
2 analysts have issued 12 month price targets for Accelerate Diagnostics' stock. Their forecasts range from $1.00 to $1.00. On average, they predic...
How has Accelerate Diagnostics' stock price performed in 2022?
Accelerate Diagnostics' stock was trading at $5.22 at the start of the year. Since then, AXDX shares have decreased by 88.3% and is now trading at...
When is Accelerate Diagnostics' next earnings date?
Accelerate Diagnostics is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022. View our earnings forecast f...
How were Accelerate Diagnostics' earnings last quarter?
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) issued its quarterly earnings data on Monday, May, 16th. The medical research company reported ($0.25) E...
Who are Accelerate Diagnostics' key executives?
Accelerate Diagnostics' management team includes the following people: Mr. Jack Phillips , CEO, Pres & Director (Age 56, Pay $703.01k) ( LinkedI...
Who are some of Accelerate Diagnostics' key competitors?
Some companies that are related to Accelerate Diagnostics include Rapid Micro Biosystems (RPID) , Standard BioTools (LAB) , IsoPlexis (ISO) , C...
What other stocks do shareholders of Accelerate Diagnostics own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Accelerate Diagnostics investors own include Himax Technol...
What is Accelerate Diagnostics' stock symbol?
Accelerate Diagnostics trades on the NASDAQ under the ticker symbol "AXDX."
What is the NASDAQ symbol for Accelerate Diagnostics?
How much does Accelerate Diagnostics make?
Accelerate Diagnostics trades on the NASDAQ under the ticker symbol "AXDX."
What is Accelerate Diagnostics?
How much money does Accelerate Diagnostics make? Accelerate Diagnostics has a market capitalization of $399.84 million and generates $11.16 million in revenue each year. The medical research company earns $-78,210,000.00 in net income (profit) each year or ($1.40) on an earnings per share basis.
Does Accelerate Diagnostics pay dividends?
is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The firm's products include Accelerate Pheno and Accelerate PhenoTest. The company was founded on May 26, 1982 and is headquartered in Tucson, AZ.
51 Biggest Movers From Yesterday
Accelerate Diagnostics does not currently pay a dividend.
5 Penny Stocks Insiders Are Buying: Tellurian, Accelerate Diagnostics And More
Check out these penny stocks insiders are buying ToughBuilt Industries, Inc. (NASDAQ: TBLT) rose 17.6% to close at $0.2863.
Accelerate Diagnostics (NASDAQ:AXDX) Price Target and Consensus Rating
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Analyst Price Target Consensus
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy).
Analyst Ratings By Month
Sign-up to receive the latest news and ratings for AXDX and its competitors with MarketBeat's FREE daily newsletter.
Average Share Price and Price Target by Month
The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Accelerate Diagnostics (NASDAQ:AXDX) Analyst Ratings Frequently Asked Questions
The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target.
When is the buy signal for 2021?
According to the issued ratings of 1 analysts in the last year, the consensus rating for Accelerate Diagnostics stock is Buy based on the current 1 buy rating for AXDX. The average twelve-month price target for Accelerate Diagnostics is $9.00 with a high price target of $9.00 and a low price target of $9.00.
Does Accelerate Diagnostics have a buy signal?
This causes a divergence and may be considered as an early warning, but it may also not. A buy signal was issued from a pivot bottom point on Friday, July 16, 2021, and so far it has risen 5.05%. Further rise is indicated until a new top pivot has been found.